Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Type 2 Diabetes on Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Hua Bian, Xiaopeng Zhu, Mingfeng Xia, et al.
Endocrine Practice (2020) Vol. 26, Iss. 4, pp. 444-453
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Simona Cernea
Life (2024) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis
Shanshan Guo, Yonghao Feng, Xiaopeng Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Update on genetics and epigenetics in metabolic associated fatty liver disease
Xiaopeng Zhu, Mingfeng Xia, Xin Gao
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 24
Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review
Ran Lu, Ye Liu, Tianpei Hong
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. S1, pp. 13-26
Closed Access | Times Cited: 15
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
Rajiv Heda, Masahiko Yazawa, Michelle Shi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 17, pp. 1864-1882
Open Access | Times Cited: 32
Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent
Santo Colosimo, Garry D. Tan, Maria Letizia Petroni, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 33, Iss. 3, pp. 640-648
Open Access | Times Cited: 19
Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models
Tannaz Jamialahmadi, Mehdi Azizmohammad Looha, Sara Jangjoo, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors
Wesal Elgretli, Mohamed Shengir, Shlomo Sasson, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 2
Open Access
Mangifera indica L. Leaves as a Potential Food Source of Phenolic Compounds with Biological Activity
Giuseppe Sferrazzo, Rosa Palmeri, Cristina Restuccia, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 18
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies
George Agyapong, Farzaneh Dashti, Bubu A. Banini
Annals of the New York Academy of Sciences (2023) Vol. 1526, Iss. 1, pp. 16-29
Open Access | Times Cited: 9
A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
Ion Cristian Efrem, Maria Moţa, Ionela Mihaela Vladu, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2426-2426
Open Access | Times Cited: 14
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD
Oluwafemi Balogun, Jeffrey Wang, Emad Salman Shaikh, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 7
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
Huimin Zou, Ying Ge, Qing Lei, et al.
Hepatology International (2022) Vol. 16, Iss. 1, pp. 27-37
Closed Access | Times Cited: 12
A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
Qiling Liu, Gang Zhao, Qian Li, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
Shraddha Shinde, David R. Nelson, Jessica Mitroi, et al.
Current Medical Research and Opinion (2023) Vol. 40, Iss. 1, pp. 59-68
Open Access | Times Cited: 5
Application of Interpretable Machine Learning Models Based on Ultrasonic Radiomics for Predicting the Risk of Fibrosis Progression in Diabetic Patients with Nonalcoholic Fatty Liver Disease
Fei Meng, Qin Wu, Wei Zhang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3901-3913
Open Access | Times Cited: 5
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years
Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, et al.
Journal of Diabetes and its Complications (2020) Vol. 35, Iss. 1, pp. 107747-107747
Closed Access | Times Cited: 14
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
Xinyu Yang, Xinxia Chang, Shengdi Wu, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Therapeutic approaches for non-alcoholic steatohepatitis
Luc F. Van Gaal, Jonathan Mertens, Sven Francque, et al.
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 12
Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non‐alcoholic fatty liver disease and metabolic dysfunction
Aurelia Radulescu, Adam Dugan, Mary Killian, et al.
Pediatric Obesity (2021) Vol. 17, Iss. 3
Closed Access | Times Cited: 12
Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease
Tansu Eris
Hepatology forum/Hepatology forum (Online) (2023)
Open Access | Times Cited: 4
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease
Xinxia Chang, Hua Bian, Mingfeng Xia, et al.
Diabetes & Metabolism (2022) Vol. 48, Iss. 6, pp. 101377-101377
Open Access | Times Cited: 7
Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia
Gashaw Abebe, Daniel Ayanaw, Tiget Ayelgn Mengstie, et al.
SAGE Open Medicine (2022) Vol. 10
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top